Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomarker Tests Need Closer Scrutiny, IOM Concludes

29 Mar 2012

Abstract excerpt

An Institute of Medicine review of flawed research at Duke University found many missteps in how scientists and physicians there developed genetic signatures to guide cancer treatment.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Nutrition, Genetics, and Disease
Share to Science, Research, and Medicine

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 22461579
DOI: 10.1126/science.335.6076.1554

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biomarker Tests Need Closer Scrutiny, IOM ConcludesPMID 22461579Read ↗

Reasons to be testing: the dawn of complex molecular profiling in routine oncology practiceSemantic proximity Read ↗

Multicancer Early Detection Tests - Keeping a High Bar for Evidence of Benefit.Semantic proximity Read ↗

Molecular Testing for Diagnostics, Prognostication, and Treatment Stratification in Cancers.Semantic proximity Read ↗

The Future of Cancer Diagnosis and Treatment: Unlocking the Power of Biomarkers and Personalized Molecular-Targeted TherapiesSemantic proximity Read ↗

Bridging Discovery and Treatment: Cancer BiomarkerSemantic proximity Read ↗

Personalized medicine using DNA biomarkers: a reviewSemantic proximity Read ↗

Special report: multiple molecular testing of cancers to identify targeted therapies.Semantic proximity Read ↗

Cancer. Developing molecular biomarkers for cancer.Semantic proximity Read ↗

Biomarker Testing for Actionable Alterations in NSCLC-Perspectives from US-Based Academic and Community Oncologists: A Podcast.Semantic proximity Read ↗

Yale Cancer Center Precision Medicine Tumor Board: molecular findings alter a diagnosis and treatment plan.Semantic proximity Read ↗

Emerging technologies for improved stratification of cancer patients: a review of opportunities, challenges, and tools.Semantic proximity Read ↗

Cancer biomarker discovery and validation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.